DeepMed Research

Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

Phase 4

Completed

Conditions: Breast Cancer

Interventions: Other: Evening administration of endocrine therapy
Other: Morning administration of endocrine therapy

First Posted Date: 2021-04-28

Last Posted Date: 2023-08-07

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 247

Registration Number: NCT04864405

Locations: 🇨🇦
Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

Tobacco-Concurrent Addictions in At-Risk Youth in Ottawa

Active, not recruiting

Conditions: Tobacco Use
Substance Use

First Posted Date: 2021-03-23

Last Posted Date: 2023-05-09

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 173

Registration Number: NCT04812613

Locations: 🇨🇦
The Bridge Engagement Centre, Ottawa, Ontario, Canada

Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab

Phase 2

Completed

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Seribantumab

First Posted Date: 2021-03-10

Last Posted Date: 2022-01-12

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 1

Registration Number: NCT04790695

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

CSRS Implementation - a Pilot Study

Active, not recruiting

Conditions: Syncope

Interventions: Other: Knowledge translation of the CSRS practice recommendations

First Posted Date: 2021-03-10

Last Posted Date: 2025-03-24

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 900

Registration Number: NCT04790058

Locations: 🇨🇦
Queensway-Carleton hospital, Ottawa, Ontario, Canada

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Phase 2

Conditions: Breast Cancer

Interventions: Drug: INT230-6
Other: Saline injection

First Posted Date: 2021-03-04

Last Posted Date: 2021-11-17

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 90

Registration Number: NCT04781725

Locations: 🇨🇦
The Ottawa Hospital Research Institute and Cancer Center, Ottawa, Ontario, Canada

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Phase 4

Completed

Conditions: Early-stage Breast Cancer

Interventions: Drug: Pegfilgrastim
Drug: Filgrastim

First Posted Date: 2021-03-04

Last Posted Date: 2025-03-21

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 233

Registration Number: NCT04781959

Locations: 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦
Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)

Phase 1

Recruiting

Conditions: Depression, Anxiety
Distress, Emotional

Interventions: Drug: Psilocybin

First Posted Date: 2021-02-15

Last Posted Date: 2024-08-09

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 20

Registration Number: NCT04754061

Locations: 🇨🇦
Bruyere Continuing Care, Ottawa, Ontario, Canada
🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Peripheral Nerve Injections for CRPS

Phase 2

Recruiting

Conditions: Complex Regional Pain Syndromes

Interventions: Drug: Saline Injection
Drug: Triamcinolone Acetonide 40mg/mL
Drug: Bupivacaine

First Posted Date: 2021-02-09

Last Posted Date: 2024-05-20

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 50

Registration Number: NCT04744675

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Elisabeth Bruyere Hospital, Ottawa, Ontario, Canada

Comparing Adductor Canal Block and Adductor Canal Block-Local Infiltration Analgesia for Post-operative Pain Management

Not Applicable

Conditions: ACL Tear
ACL
ACL Injury

Interventions: Procedure: Local Infiltration Anesthetic
Procedure: Local Infiltration Anesthetic + Adductor Canal Block

First Posted Date: 2021-01-22

Last Posted Date: 2021-01-22

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 100

Registration Number: NCT04721119

Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool

Phase 1

Completed

Conditions: Airway Extubation

Interventions: Device: Extubation Advisor

First Posted Date: 2021-01-14

Last Posted Date: 2025-05-15

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 31

Registration Number: NCT04708509

Locations: 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy